SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.095
NA - Nord America 1.831
EU - Europa 647
SA - Sud America 366
AF - Africa 67
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.748
SG - Singapore 945
CN - Cina 399
BR - Brasile 270
VN - Vietnam 235
HK - Hong Kong 207
IT - Italia 172
FI - Finlandia 96
DE - Germania 87
IN - India 62
FR - Francia 50
ID - Indonesia 50
GB - Regno Unito 49
UA - Ucraina 48
MX - Messico 43
RU - Federazione Russa 42
JP - Giappone 39
AR - Argentina 38
BD - Bangladesh 30
ZA - Sudafrica 28
CA - Canada 27
IQ - Iraq 20
NL - Olanda 18
AT - Austria 17
EC - Ecuador 17
TR - Turchia 17
PH - Filippine 16
PL - Polonia 16
ES - Italia 12
CO - Colombia 11
SE - Svezia 10
MA - Marocco 9
KE - Kenya 8
PK - Pakistan 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
LT - Lituania 7
MY - Malesia 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
JO - Giordania 6
EG - Egitto 5
NP - Nepal 5
BA - Bosnia-Erzegovina 4
UY - Uruguay 4
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
KG - Kirghizistan 3
PE - Perù 3
PS - Palestinian Territory 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ET - Etiopia 2
IE - Irlanda 2
KH - Cambogia 2
MN - Mongolia 2
PA - Panama 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GP - Guadalupe 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MV - Maldive 1
NG - Nigeria 1
NI - Nicaragua 1
PT - Portogallo 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.009
Salva come PNG Salva come JPEG
Città #
Singapore 568
San Jose 316
Ashburn 294
Santa Clara 270
Hong Kong 203
Beijing 112
Ho Chi Minh City 86
Helsinki 85
Council Bluffs 52
Hanoi 52
Los Angeles 52
Houston 40
Jakarta 40
Tokyo 39
Woodbridge 37
Fairfield 36
Jacksonville 29
São Paulo 29
Chicago 28
Dallas 28
Lauterbourg 28
Mexico City 26
New York 26
Ferrara 23
Nuremberg 23
Hefei 22
Milan 20
Shanghai 20
Orem 19
Bologna 18
Dearborn 16
Seattle 15
Warsaw 14
Atlanta 13
Baghdad 12
Frankfurt am Main 12
London 12
San Francisco 12
Brooklyn 11
Chennai 11
Da Nang 11
Johannesburg 11
Cambridge 10
Chandler 10
Falkenstein 10
Toronto 10
Wilmington 10
Haiphong 9
Montreal 9
Curitiba 8
Rio de Janeiro 8
Boardman 7
Guangzhou 7
Manchester 7
Rome 7
Tashkent 7
Vienna 7
Amsterdam 6
Denver 6
Guayaquil 6
Hải Dương 6
Izmir 6
Mumbai 6
Nanjing 6
Stockholm 6
Amman 5
Biên Hòa 5
Boston 5
Buffalo 5
Guarulhos 5
Lappeenranta 5
Manila 5
Nairobi 5
Nanchang 5
New Delhi 5
Phoenix 5
Poplar 5
Princeton 5
Quito 5
Salt Lake City 5
San Diego 5
Ann Arbor 4
Assago 4
Asunción 4
Belo Horizonte 4
Forlì 4
Montevideo 4
Moscow 4
Munich 4
Banja Luka 3
Bishkek 3
Brasília 3
Buenos Aires 3
Bình Dương 3
Cape Town 3
Casablanca 3
Caxias do Sul 3
Cleveland 3
Cupramontana 3
Delhi 3
Totale 3.090
Salva come PNG Salva come JPEG
Nome #
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 181
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 170
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 153
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 150
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 134
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 126
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma 111
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 107
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 107
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 101
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 100
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 98
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 97
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 96
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 92
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 88
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 86
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 79
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 78
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 78
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 78
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 78
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 77
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 75
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 75
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 75
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 74
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 73
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 72
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 72
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 72
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 70
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 70
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 70
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 69
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 69
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 68
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 67
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 66
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 66
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 66
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 65
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 63
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 62
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 58
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 58
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 57
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 50
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 50
Melanoma vaccines in development 43
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 41
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 39
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 37
IDIOTYPIC VACCIN 34
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 34
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 31
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 31
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 31
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 30
Circulating memory B-cell receptor repertoire analysis identifies novel candidate antibodies against metastatic melanoma in immunotherapy-responsive patients 30
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 29
Ipilimumab in advanced melanoma: reports of long-lasting responses 29
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 28
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 28
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 27
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 27
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 27
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 26
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 26
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 25
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 25
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy 24
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 24
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 24
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 24
Epigenetic remodelling of DNA in cancer 22
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial 21
First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax) 20
MicroRNAs and dendritic cell-based vaccination in melanoma patients 20
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 19
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 18
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 17
Randomized, Open-Label, Phase III Study of Tilsotolimod in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced Refractory Melanoma (ILLUMINATE-301) 15
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma 15
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 12
Diagnostic accuracy of 18F-FDG PET/CT in muscle-invasive bladder cancer: rationale and design of the MIBC-PET study 6
Totale 5.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 230
Totale 27.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 7 9 2
2021/202257 4 4 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/20251.281 38 105 69 7 189 166 31 41 192 206 133 104
2025/20263.311 269 109 272 415 526 209 451 217 417 426 0 0
Totale 5.156